For the ACT program design using innovative and adaptive methodology to find a safe, effective treatment to slow the progression of COVID-19 across 80 sites in 8 countries over 6 months.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. John EikelboomResearch Location
CanadaLead Research Institution
McMaster UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
For the ACT program design using innovative and adaptive methodology to find a safe, effective treatment to slow the progression of COVID-19 across 80 sites in 8 countries over 6 months.